Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (8473)
All Articles published online
|
Featured Article
|
Publishing Process of This Article
|
Oct 8, 2015 (publication date) through Nov 9, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Hepatology
ISSN
1948-5182
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Honda K, Seike M, Murakami K. Benefits of nucleos(t)ide analog treatments for hepatitis B virus-related cirrhosis. World J Hepatol 2015; 7(22): 2404-2410 [PMID: 26464756 DOI: 10.4254/wjh.v7.i22.2404] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v7/i22/2404.htm |
| Number | Citing Articles |
| 1 |
Zheng-xin Li, Zhi-min Zhao, Ping Liu, Qing-shan Zheng, Cheng-hai Liu. Treatment of HBV Cirrhosis with Fuzheng Huayu Tablet (扶正化瘀片) and Entecavir: Design of a Randomized, Double-Blind, Parallel and Multicenter Clinical Trial. Chinese Journal of Integrative Medicine 2021; 27(7): 509 doi: 10.1007/s11655-020-3257-6
|
| 2 |
Ryan Taylor Anderson, Seng Gee Lim, Poonam Mishra, Filip Josephson, Eric Donaldson, Bruce Given, Veronica Miller. Challenges, Considerations, and Principles to Guide Trials of Combination Therapies for Chronic Hepatitis B Virus. Gastroenterology 2019; 156(3): 529 doi: 10.1053/j.gastro.2018.11.062
|
| 3 |
Ming‐Tsung Lin, Kuo‐Chin Chang, Chih‐Chi Wang, Sherry Yueh‐Hsia Chiu, Chee‐Chien Yong, Yueh‐Wei Liu, Wei‐Feng Li, Jing‐Houng Wang, Chao‐Cheng Huang, Chang‐Chun Hsiao, Ming‐Hong Tai, Tsung‐Hui Hu. Comparison of serum WFA+‐M2BP, FIB‐4, and APRI for cirrhosis and esophageal varices prediction in hepatoma patients. Advances in Digestive Medicine 2024; 11(3): 119 doi: 10.1002/aid2.13369
|
| 4 |
Sammy Saab, Ping-yu Chen, Clara E. Saab, Myron J. Tong. The Management of Hepatitis B in Liver Transplant Recipients. Clinics in Liver Disease 2016; 20(4): 721 doi: 10.1016/j.cld.2016.06.004
|
| 5 |
Chueh-Ling Liu, Cheng-Kun Wu, Hon-Yi Shi, Wei-Chen Tai, Chih-Ming Liang, Shih-Cheng Yang, Keng-Liang Wu, Yi-Chun Chiu, Seng-Kee Chuah. Medical expenses in treating acute esophageal variceal bleeding. Medicine 2016; 95(28): e4215 doi: 10.1097/MD.0000000000004215
|
| 6 |
M.‐L. Wang, E.‐Q. Chen, D.‐M. Zhang, L.‐Y. Du, L.‐B. Yan, T.‐Y. Zhou, X.‐Z. Lei, B.‐J. Lei, J.‐J. Lu, J. Liao, H. Tang. Efficacy and safety of three adefovir‐based combination therapies in HBeAg‐positive chronic hepatitis B patients with suboptimal response to adefovir monotherapy. Journal of Viral Hepatitis 2017; 24(S1): 21 doi: 10.1111/jvh.12792
|
| 7 |
Ahmad Hormati, Maryam Jameshorani, Seyed Saeed Sarkeshikian , Mansureh Molaei, Mahdi Jahangiri, Mohammad Reza Ghadir. Effects of Atorvastatin Alongside Conventional Medical Treatment on Liver Fibrosis and Dysfunction in Patients with Chronic Hepatitis B: A Double-Blinded Clinical Trial. Hepatitis Monthly 2019; (In Press) doi: 10.5812/hepatmon.84656
|
| 8 |
Aunchalee Jaroenlapnopparat, Maneerat Chayanupatkul, Pisit Tangkijvanich. Novel viral markers and the prediction of off‐treatment relapse in chronic hepatitis B patients: A systematic review. Journal of Gastroenterology and Hepatology 2021; 36(9): 2349 doi: 10.1111/jgh.15516
|
| 9 |
Yunqi Liu, Ximei Wang, Fuping Xu, Dengren Li, Huimin Yang, Nan Sun, Yu-Chen Fan, Xiangdong Yang. Risk Factors of Chronic Kidney Disease in Chronic Hepatitis B: A Hospital-based Case-control Study from China. Journal of Clinical and Translational Hepatology 2022; 10(2): 238 doi: 10.14218/JCTH.2021.00082
|
| 10 |
|
| 11 |
Christine Sempoux, Maria Guido, Romil Saxena. Practical Hepatic Pathology: a Diagnostic Approach. 2018; : 679 doi: 10.1016/B978-0-323-42873-6.00041-X
|